Search

everythinglearnresearchcommunity

for

Search:↓

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

Red fluorescence in AGA scalps is linked to different microbes.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

XEDAR triggers a specific signaling pathway in cells.

Chicken feather gene mutation helps understand human hair disorders.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Immune changes and specific genes contribute to male hair loss.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

CD2 might be a new treatment target for patchy alopecia areata.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.